Fundz

Novocure secures new $400 million multi-tranche non-dilutive debt financing from Pharmakon

PUBLIC · NVCRMay 02, 2024

Amount Raised

$400 Million

Round Type

Debt Financing

ZugBiotechnologyHealth CareMedicalTherapeutics

Investors

Pharmakon Advisors, LP

Description

Novocure announced a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. The proceeds will be used to fund working capital needs stemming from Novocure’s anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure’s convertible notes.

Quick answer

Novocure raised $400 Million in a Debt Financing round, dated May 2, 2024. Investors: Pharmakon Advisors, LP. Novocure is based in Zug, Zug, Switzerland.

How much did Novocure raise?
Novocure raised $400 Million in a Debt Financing round on May 2, 2024.
Who invested in Novocure?
Pharmakon Advisors, LP is named as investors in this round.
What does Novocure do?
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields.
Where is Novocure based and how big is it?
Novocure is based in Zug, Zug, Switzerland. Fundz records about 1,467 employees.
Who are the decision-makers at Novocure?
Fundz holds 4 contacts at Novocure, including the Senior Talent Acquisition Partner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Novocure that raised within 45 days of this round, from Fundz verified event records.

  • Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.
  • Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.
  • Scipher Medicine raised $25M on May 2, 2024.
  • neurocare raised $17M (Funding Round) on April 24, 2024.
  • Hubly raised $1.3M on June 14, 2024.
  • InduPro raised $85M (Series A) on June 13, 2024.

Who to call at Novocure, and when

A new round usually means Novocure is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Novocure raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Novocure, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Novocure. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Novocure

Location

Zug, Zug, Switzerland

About

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma. Novocure has ongoing or completed clinical studies investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Novocure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsGalit K., Senior Talent Acquisition Partner hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Novocure's next move

See what Strategic adds

Novocure raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.